JPWO2020171055A1 - - Google Patents

Info

Publication number
JPWO2020171055A1
JPWO2020171055A1 JP2020538735A JP2020538735A JPWO2020171055A1 JP WO2020171055 A1 JPWO2020171055 A1 JP WO2020171055A1 JP 2020538735 A JP2020538735 A JP 2020538735A JP 2020538735 A JP2020538735 A JP 2020538735A JP WO2020171055 A1 JPWO2020171055 A1 JP WO2020171055A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020538735A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020171055A1 publication Critical patent/JPWO2020171055A1/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2020538735A 2019-02-19 2020-02-18 Pending JPWO2020171055A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019026982 2019-02-19
PCT/JP2020/006243 WO2020171055A1 (ja) 2019-02-19 2020-02-18 ベンゾアゼピン誘導体のアルコール和物又はその結晶

Publications (1)

Publication Number Publication Date
JPWO2020171055A1 true JPWO2020171055A1 (es) 2020-08-27

Family

ID=72144597

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020538735A Pending JPWO2020171055A1 (es) 2019-02-19 2020-02-18

Country Status (2)

Country Link
JP (1) JPWO2020171055A1 (es)
WO (1) WO2020171055A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2642783C2 (ru) * 2012-12-26 2018-01-26 Санва Кагаку Кенкюсо Ко., Лтд. Новое производное бензоазепина и его медицинское применение

Also Published As

Publication number Publication date
WO2020171055A1 (ja) 2020-08-27

Similar Documents

Publication Publication Date Title
BR112019017762A2 (es)
BR112021017339A2 (es)
BR112021018450A2 (es)
BR112021013854A2 (es)
BR112019016141A2 (es)
BR112021008711A2 (es)
BR112019016138A2 (es)
BR112019016142A2 (es)
BR112021018168A2 (es)
AU2020104490A5 (es)
BR112021018452A2 (es)
BR112021017234A2 (es)
BR112021017355A2 (es)
BR112021017703A2 (es)
BR112021018102A2 (es)
BR112021017173A2 (es)
BR112021018584A2 (es)
BR112021017083A2 (es)
BR112021017637A2 (es)
BR112021015080A2 (es)
BR112021012348A2 (es)
BR112021018250A2 (es)
BR112021018084A2 (es)
BR112021013944A2 (es)
BR112021013128A2 (es)

Legal Events

Date Code Title Description
AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20211109

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211129